Abstract:Background: Elevated levels of S-adenosylhomocysteine (SAH), the precursor of homocysteine, are positively associated with the risk of cardiovascular disease and with the development and progression of atherosclerosis. However, the role of SAH in endothelial dysfunction is unclear. Methods: Apolipoprotein E–deficient (apoE−/−) mice received dietary supplementation with the SAH hydrolase (SAHH) inhibitor adenosine dialdehyde or were intravenously injected with a retrovirus expressing SAHH shRNA. These 2 approaches, along with the heterozygous SAHH gene knockout (SAHH+/−) mouse model, were used to elevate plasma SAH levels and to examine the role of SAH in aortic endothelial dysfunction. The relationship between plasma SAH levels and endothelial dysfunction was also investigated in human patients with coronary artery disease and healthy control subjects. Results: Plasma SAH levels were increased in SAHH+/− mice and in apoE−/− mice after dietary administration of adenosine dialdehyde or intravenous injection with SAHH shRNA. SAHH+/− mice or apoE−/− mice with SAHH inhibition showed impaired endothelium-dependent vascular relaxation and decreased nitric oxide bioavailability after treatment with acetylcholine; this was completely abolished by the administration of the endothelial nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester. Furthermore, SAHH inhibition induced production of reactive oxygen species and p66shc expression in the mouse aorta and human aortic endothelial cells. Antioxidants and p66shc siRNA prevented SAHH inhibition–induced generation of reactive oxygen species and attenuated the impaired endothelial vasomotor responses in high-SAH mice. Moreover, inhibition of SAHH induced hypomethylation in the p66shc gene promoter and inhibited expression of DNA methyltransferase 1. Overexpression of DNA methyltransferase 1, induced by transduction of an adenovirus, was sufficient to abrogate SAHH inhibition–induced upregulation of p66shc expression. Finally, plasma SAH levels were inversely associated with flow-mediated dilation and hypomethylation of the p66shc gene promoter and positively associated with oxidative stress levels in patients with coronary artery disease and healthy control subjects. Conclusions: Our findings indicate that inhibition of SAHH results in elevated plasma SAH levels and induces endothelial dysfunction via epigenetic upregulation of the p66shc-mediated oxidative stress pathway. Our study provides novel molecular insight into mechanisms of SAH-associated endothelial injury that may contribute to the development of atherosclerosis. Clinical Trial Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT03345927.

Hyperhomocysteinemia: a missing link to dysfunctional HDL via paraoxanase-1

Paraoxonase 1 interactions with atherosclerotic lesions and arterial macrophages protect against foam cell formation and atherosclerosis development

Reduced Number and Activity of Circulating Endothelial Progenitor Cells from Patients with Hyperhomocysteinemia.

Hepatic paraoxonase 1 ameliorates dysfunctional high-density lipoprotein and atherosclerosis in scavenger receptor class B type I deficient mice

The Molecular Bases of Anti-Oxidative and Anti-Inflammatory Properties of Paraoxonase 1

Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation

Diet-Induced Severe Hyperhomocysteinemia Promotes Atherosclerosis Progression and Dysregulates the Plasma Metabolome in Apolipoprotein-E-Deficient Mice

Hyperhomocysteinemia Potentiates Endothelial Dysfunction in Diabetes by Calpain and NADPH Oxidase Activation

Homocysteine Impaired Endothelial Function Through Compromised Vascular Endothelial Growth Factor/Akt/Endothelial Nitric Oxide Synthase Signalling

Homocysteine impaired endothelial function via compromised VEGF/Akt/eNOS signaling (Revised 1)

Hyperhomocysteinemia aggravates endothelial dysfunction via EDHF impairment in resistant arteries of db/db mice (1051.13)

Hyperhomocysteinemia and Hyperglycemia Induce and Potentiate Endothelial Dysfunction Via Μ-Calpain Activation

Paraoxonase 1 Phenotype and Protein N-Homocysteinylation in Patients with Rheumatoid Arthritis: Implications for Cardiovascular Disease

Inhibition of S-Adenosylhomocysteine Hydrolase Induces Endothelial Dysfunction Via Epigenetic Regulation of P66shc-Mediated Oxidative Stress Pathway

Hyperhomocysteinemia Promotes Inflammatory Monocyte Generation and Accelerates Atherosclerosis in Transgenic Cystathionine Beta-Synthase-Deficient Mice

Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex.

HHcy Induces Pyroptosis and Atherosclerosis Via the Lipid Raft-Mediated NOX-ROS-NLRP3 Inflammasome Pathway in Apoe−/− Mice

Hyperhomocysteinemic Diabetic Cardiomyopathy: Oxidative Stress, Remodeling, and Endothelial-Myocyte Uncoupling

Hypercysteinemia promotes atherosclerosis by reducing protein S-nitrosylation.

Hyperhomocysteinemia Decreases Circulating High-Density Lipoprotein by Inhibiting Apolipoprotein A-I Protein Synthesis and Enhancing HDL Cholesterol Clearance

Homocysteine Causes Endothelial Dysfunction via Inflammatory Factor-Mediated Activation of Epithelial Sodium Channel (ENaC)